Drug helps blood vessels but leaves lurking cancer cells | Touch Latest Local,World,Tech,Entertainment,Health,Sport News
22 September 2017 00:00:00 AM Breaking News


Drug helps blood vessels but leaves lurking cancer cells

Drug cuts the supply lines to brain tumors but doesn’t eliminate cancer stem cells, which could explain resistance to the drug.When given to patients newly diagnosed with aggressive brain cancer, the drug bevacizumab reduces the density of blood vessels in tumors but shunts cancer stem cells to areas where blood vessels are still functioning normally, find Keio researchers. This discovery, from a first-of-its-kind investigation of bevacizumab’s microscopic effects, should help cancer researchers better understand the mechanisms of resistance to the drug and so design combination strategies that promote patient survival.

Sold under the brand name Avastin, bevacizumab works by blocking a protein involved in the formation of new blood vessels, thereby choking off the blood supply that normally fuels the growth and spread of cancer cells. The drug is approved in many parts of the world for patients whose glioblastoma brain tumors have returned after initial treatment. In Japan, it is also available as a front-line therapy.

In clinical studies, bevacizumab has been shown to delay tumor growth and improve patient function. However, the drug did not extend patients’ lives. When the cancer recurred after treatment, it tended to come back with a vengeance — and now Hikaru Sasaki and Ryota Tamura, neurosurgeons at the Keio University School of Medicine, have an idea why that is.

Sasaki, Tamura and their colleagues collected tumor samples from six patients with glioblastomas who underwent surgery shortly after treatment with bevacizumab. They also analyzed tumor samples from eleven patients who did not receive the drug. Across the treated tumors, the researchers saw that bevacizumab dramatically affected blood vessels: they became less dense; they no longer proliferated; and oxygen levels recovered1. In a separate study, Sasaki and his team also found that blood vessel congestion might be involved2.

However, the therapy never completely wiped out the cancer stem cells that seeded the recurrence of the disease. While it did eliminate one of the places where cancer stem cells are often found, when the researchers looked for nestin, a protein that indicates the presence of cancer stem cells, they found it clustered around the remaining blood vessels in a spot called the perivascular niche.

“Combination therapies that target the perivascular niche might be a rational approach to treat glioblastomas more efficiently,” says Sasaki, noting that the persistence of cancer stem cells “might constitute one of the mechanisms of resistance to bevacizumab.”

Sasaki and his colleagues are currently running a prospective trial to clarify the mechanisms of resistance and to identify biomarkers that might predict likely responders to bevacizumab.



Related Posts

Growing tobacco affects the environment – W.H.O.

The World Health Organization says tobacco growing causes massive harm to theenv

Read More

Somaliland: 'Things are worse now than two months ago'

The Governor of Somaliland’s drought-ravaged eastern province of Togdhee

Read More

Why Hair Turns Gray

Unless you dye, your hair eventually loses its color, usually beginning in you

Read More

Natural-born killers: The fruits and veggies that could poison you

Underneath its spiky exterior, the fruit is smooth, juicy and beautifully sweet.

Read More

Health news — April 12, 2017

Discovery Memory Care, 408 W. Washington St., Sequim, will hosts a bi-monthly su

Read More

16 Health Benefits of Pilates, According to Science (+10 Tips for Beginners)

In the 1920’s, a man by the name of Joseph Pilates observed people doing y

Read More

You Will NEVER Again Throw Away Onion Peels After Reading This

If you knew that something you usually throw away has a lot of benefits, would y

Read More

Nonlethal Targeting of Gut Microbes Successfully Treats Atherosclerosis

Study heralds potential new approach to cardiometabolic diseases The once-i

Read More

New drug target found for most common cancer in infants

Researchers have identified a new target for immunotherapies that could treat an

Read More

Zika Found in Common Backyard Asian Tiger Mosquito

A common backyard mosquito can be infected with the Zika virus and it may pas

Read More

Also Read

South Sudan forces killed 114 civilians around Yei in six months...

South Sudanese pro-government forces killed at least 114 civilians in and a

Read More

El-Rufai smiles with Tinubu in daylight but stings him at night – Shehu Sani

El-Rufai smiles with Tinubu in daylight but stings him at night – Shehu SaniSe

Read More

Rumours: Zlatan Ibrahimovic expects to leave Man United in summer after suffering serious knee injury

Zlatan Ibrahimovic has accepted his Manchester United career is over after

Read More

United to offer passengers up to $10,000 to surrender seats

NEW YORK: United Airlines said on Thursday it would offer passengers who volunte

Read More

10 of the best things you can do with the Amazon Echo

If you're considering buying an Alexa device (including the new Echo Show or Ech

Read More

Seven die, 136 missing in Kebbi boat accident

No fewer than seven people have died and seven hospitalized in Ngaski Local G

Read More

The iPhone Model's Impending Obsolescence

It is easy to look back on technology changes and see that we had plenty of warn

Read More

Ajimobi inaugurates board of Oyo ETF

Gov. Abiola Ajimobi of Oyo State on Monday inaugurated the newly constituted b

Read More

Veteran crime reporter shot dead in Mexico Veteran crime reporter shot dead in Mexico

An award-winning veteran crime reporter identified as Javier Valdez who has been

Read More

Nigeria invites Teluwo, Holmes, Inyang for ITF/CAT Junior Championships

Nigeria has invited Serena Teluwo, Reya Holmes, Daniel Adeleye and Gabriel Inyan

Read More